Historical record - last NADAC publication: 5/22/2024
Product Information
TEMOZOLOMIDE 140 MG CAPSULE is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $10.7251 per EA under NDC 47335092980. Its NADAC has been published 159 times since Apr 9, 2014.
The High Outlier badge above means this manufacturer's average price in the Temozolomide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
140 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
47335092980
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
5/22/2024
Active Ingredients
TEMOZOLOMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA201742On Market Since
2/13/2014
Pharmacological Classes
Price Statistics
The NADAC for TEMOZOLOMIDE 140 MG CAPSULE has been published 159 times since Apr 9, 2014, and over the history we have for it it has declined 95.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.7251 per EA |
|---|---|
| All-time high | $249.3008 (Jul 16, 2014) |
| All-time low | $10.7251 (Apr 17, 2024) |
| Median price | $183.7700 |
| Average price | $115.3921 |
| Largest weekly change | -92.5% (Jul 21, 2021) |
| Weeks tracked | 159 |
| Tracking since | Apr 9, 2014 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TEMOZOLOMIDE 140 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TEMOZOLOMIDE 140 MG CAPSULE, manufactured by Sun Pharmaceutical Industries Inc., is $10.7251 per EA (NDC 47335092980), effective Aug 14, 2024.
How has the price of TEMOZOLOMIDE 140 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TEMOZOLOMIDE 140 MG CAPSULE has declined 95.7%. It has been tracked across 159 weekly CMS publications since Apr 9, 2014.
What are the highest and lowest recorded NADAC prices for TEMOZOLOMIDE 140 MG CAPSULE?
Since Apr 9, 2014, the NADAC for TEMOZOLOMIDE 140 MG CAPSULE has ranged from a low of $10.7251 (Apr 17, 2024) to a high of $249.3008 (Jul 16, 2014), with a median of $183.7700 per EA.
Are there cheaper alternatives to TEMOZOLOMIDE 140 MG CAPSULE?
6 NADAC-published products share the same active ingredient, strength, and dosage form as TEMOZOLOMIDE 140 MG CAPSULE, but none are currently priced below it.
Who manufactures TEMOZOLOMIDE 140 MG CAPSULE?
TEMOZOLOMIDE 140 MG CAPSULE (NDC 47335092980) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification